Investigative work by ZachXBT, an independent blockchain investigator, has played a critical role in a class action lawsuit filed in Canada against Boneheads, an alleged NFT rug-pull that resulted in $3.1 million in losses.
On July 7th, ZachXBT shared details of the lawsuit on Twitter and reiterated the allegations against the Boneheads team. He stated that the team quickly disappeared, misused the funds generated from the project, and failed to follow the promised roadmap. The misused funds allegedly went towards purchasing Bored Ape Yacht Club NFTs, luxury items, and undisclosed expenses.
ZachXBT expressed satisfaction that its research and investigative efforts were once again cited in a legal case, and emphasized the importance of its work in uncovering fraudulent activity.
Read more on the subject and find the latest business news of the day with the Born2Invest mobile app.
ZachXBT’s investigative work has been instrumental in several cases involving malicious actors in the NFT space
The class action lawsuit was initially filed in the Ontario Superior Court of Justice in mid-June. The lawsuit, filed June 19, alleges the Boneheads team breached its contract with investors by failing to follow the project’s roadmap, misusing funds, making fraudulent and negligent misrepresentations, and committing other crimes.
The lawsuit emphasizes that none of the promised benefits, including NFT airdrops, tokens, physical collectibles, market access, forgery, avatar applications, voting rights, giveaways, or other obligations, were fulfilled by the Boneheads NFT team.
ZachXBT’s posts are referenced in the lawsuit and highlight his investigation of the Boneheads project, which he shared on Twitter in July 2022 and in subsequent posts the following month. In his initial Twitter thread, ZachXBT explained how the project allegedly misused funds intended to support the Boneheads roadmap. He also identified key individuals involved in the project and documented their questionable actions.
Despite months of inactivity on social media, the Boneheads team promptly responded to ZachXBT’s posts on Twitter, dismissing the fraud allegations and attributing the project’s slow progress to a deliberate and creative process. They even announced the release of a new collection called “21” for the project’s anniversary in August 2022, but that collection never materialized.
ZachXBT’s investigative work has been instrumental in several cases involving malicious actors in the NFT space. In February, the FBI seized 86.5 Ether and $100,000 worth of NFTs from a phishing scammer as a result of its extensive investigation. In addition, in October 2022, the French National Cyber Unit recognized ZachXBT’s work in supporting its efforts to arrest and indict a group of suspected phishing fraudsters who allegedly stole $2.5 million worth of NFTs.
ZachXBT’s ongoing commitment to investigating fraudulent activity in the blockchain and NFT sectors has been invaluable in exposing wrongdoing and holding those responsible for defrauding investors and participants in these markets accountable. His work serves to protect the integrity of the industry and promote the trust of its participants.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in COIN KURIER, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Jazz Pharmaceuticals’ Leukemia Drug Receives European Commission Approval
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to the development of drugs in neuroscience and oncology. Founded in 2003 in...
Citi Announced a $6 Million Loan to Sempli for SME financing
The credit granted by Citi was given in partnership with high-impact investors and multilateral development organizations. They all seek to...
How Will the Price of Ripple and Cardano Develop in the Next Few Days
The BOLL indicator shows no specific pattern and denotes the support price of $0.4969 and the resistance price of $0.5059,...
RADEEF: a 182 Million Dirham Plan to Combat Flooding in Morocco
RADEEF is also planning major expansion projects. Firstly, it plans to launch work on extending the wastewater treatment plant. The...
How Institutional Investors Feel About Impact Investing
Investors continue to face greenwashing when implementing impact investing. Among their key concerns are misleading or exaggerated impact claims (60%),...
Fintech2 weeks ago
Fintech Company Cleafy Raises €10 million
Crypto2 days ago
Coinbase Now Holds as Much Bitcoin as Satoshi Nakamoto, Arkham Reveals
Crypto1 week ago
Ripple’s IPO Plans – What Do They Mean for XRP?
Biotech2 weeks ago
Murcia Puts Out to Tender for €500,000 the Works of the Clinical Trials Unit in Arrixaca